Department of Pharmacy Practice

College of Pharmacy
masthead

Jeremy Johnson

 Jeremy Johnson Jeremy Johnson, PharmD, PhD
Assistant Professor
Department of Pharmacy Practice
Email jjjohn@uic.edu
Phone 312-996-4368
Fax 312-996-0379
Office 117A
US Mail 833 South Wood Street, RM164 MC886, Chicago, IL 60612

Research Interests
The primary objective of Dr. Johnson’s research group is to create a model to successfully translate promising chemical entities from natural sources for cancer chemoprevention from pre-clinical research to phase I human clinical trials.  As an example, ongoing projects are investigating phytochemicals from the Mediterranean herb Rosemary and the mangosteen fruit for cancer chemoprevention and/or chemotherapy applications.  These unique phytochemicals are being evaluated for understanding their mechanism of action, pharmacokinetic properties, and in vivo efficacy in animal models. 

Education
2010
Fellowship in Clinical and Translational Science, NIH CTSA KL2 Scholar
2010
Doctor of Philospohy (PhD), University of Wisconsin-Madison
2007
Doctor of Pharmacy (PharmD), University of Wisconsin-Madison
2001
Bachelor of Science (BS, Biology), University of Wisconsin Stevens Point


Current UIC Appointments
Assistant Professor, Department of Pharmacy Practice, College of Pharmacy
Leader, Pre-Clinical Development, UICENTRE
Clinical Pharmacist, Department of Pharmacy Practice, College of Pharmacy

     Representative Publications
  1. Johnson JJ, Syed DS, Suh Y, Heren CR, Saleem M, Siddiqui IA, Mukhtar H. Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol: implications for chemoprevention. Cancer Prev Res. 2010;3:1112-23. PMID: 20736335
  2. Johnson JJ, Bailey H, Mukhtar H. Green tea polyphenols for prostate cancer chemoprevention: A translational perspective. Phytomedicine. 2010;17:3-13. PMID: 19959000
  3. Johnson JJ, Syed DN, Heren CR, Suh Y, Adhami VM, Mukhtar H. Carnosol, a dietary diterpene, displays growth inhibitory effects in human prostate cancer PC3 cells leading to G2-phase cell cycle arrest and targets the 5'-AMP-activated protein kinase (AMPK) pathway. Pharm Res. 2008. 25: 2125-34. PMID: 18286356
  4. Saleem M, Kweon MH, Johnson JJ, Adhami VM, Elcheva I, Khan N, Bin Hafeez B, Bhat KM, Sarfaraz S, Reagan-Shaw S, Spiegelman VS, Setaluri V, Mukhtar H. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci U S A. 2006;103:14825-30. PMID: 16990429
  5. Johnson JJ, Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett. 2007 Oct 8;255(2):170-81. PMID: 17448598

Click here to view Dr. Johnson's on-line CV. PDF logo

Return to faculty list